Table 2 Immunohistological Staining results of the positively screened patient cohort.
Case | 1 | 2 | 3 | 4 | 5 | 6 |
|---|---|---|---|---|---|---|
Sex | M | M | M | F | M | M |
Age | 46 | 63 | 66 | 72 | 66 | 68 |
CK7 | 2% | 0% | 5% | 15% | 0% | 5% |
SMARCA4 | 100% | 100% | 100% | 100% | 100% | 100% |
ARID1a | 0% | 100% | 100% | 100% | 100% | 100% |
SMARCA2 | 0% | 0% | 10% | 0% | 10% | 15% |
AFP | 2% | 10% | 0% | 10% | 90% | 0% |
Claudin-6 | 85% | 100% | 80% | 100% | 70% | 90% |
Glypican 3 | 70% | 100% | 80% | 100% | 85% | 80% |
SALL4 | 15% | 80% | 5% | 100% | 40% | 10% |